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Abstract
Background: Fractional flow reserve (FFR) is considered the gold 
standard for diagnosis of coronary artery disease (CAD). Stress Car-
diac magnetic resonance (SCMR) has been recently gaining traction 
as a non-invasive alternative to FFR. 
Methods: Studies comparing the diagnostic accuracy of SCMR ver-
sus FFR were identified and analyzed using Review Manager (Rev-
Man) 5.3 and Stata software.
Results: A total of 28 studies, comprising 2,387 patients, were includ-
ed. The pooled sensitivity and specificity for SCMR were 86% and 
86% at the patient level, and 82% and 88% at the vessel level, respec-
tively. When the patient-level data were stratified based on the FFR 
thresholds, higher sensitivity and specificity (both 90%) were noted 
with the higher cutoff (0.75) and lower cutoff (0.8), respectively. At 
the vessel level, sensitivity and specificity at the lower FFR threshold 
were significantly higher at 88% and 89%, compared to the corre-
sponding values for higher cutoff at 0.75. Similarly, meta-regression 
analysis of SCMR at higher (3T) resolution showed a higher sensitiv-
ity of 87% at the patient level and higher specificity of 90% at the 
vessel level. The highest sensitivity and specificity of SCMR (92% 
and 94%, respectively) were noted in studies with CAD prevalence 
greater than 60%.
Conclusions: SCMR has high diagnostic accuracy for CAD compa-
rable to FFR at a spatial resolution of 3T and an FFR cut-off of 0.80. 
An increase in CAD prevalence further improved the specificity of 
SCMR.
Keywords: Cardiac magnetic resonance; Fractional flow reserve; 
Coronary stenosis
Introduction
The interpretation of invasive coronary angiography (ICA) 
based on anatomic reference standard has been the sole diag-
nostic modality for coronary artery disease (CAD) for a long 
time [1]. However, fractional flow reserve (FFR) and stress 
cardiac magnetic resonance (SCMR) are now coming into 
more frequent use. Recent studies have demonstrated the dis-
cordance between FFR and ICA, especially at the extremes of 
the angiographic spectrum (stenosis less than 30% or greater 
than 90%) [1]. Thus, an assumption of functional relevance 
based merely on the angiographic appearance of stenosis in 
the absence of FFR can be misleading. FFR appears to be more 
precise for the depiction of lesion-specific ischemia but at the 
cost of radiation exposure and an invasive procedure. SCMR 
perfusion scans have been suggested as an alternative to guide 
clinical decision-making, particularly in cases of CAD with 
stenosis of 50-75% [2]. Our study adds to the existing litera-
ture by pooling all available data to determine the diagnostic 
accuracy of SCMR for diagnosing CAD severity when com-
pared to the gold-standard FFR.
Materials and Methods
Search strategy
A literature search for relevant articles was performed using 
PubMed, Ovid, Embase, clinicaltrials.gov, and Cochrane da-
tabases. There was no language or time restriction. The search 
strategies included various combinations of text-words and 
medical subject headings (MeSH) to generate two subsets 
of citations: one for magnetic resonance imaging using the 
terms such as “MRI”, “magnetic resonance imaging”, “mag-
netic resonance perfusion”, “cardiac MRI”, “SCMRI”, “MR 
perfusion imaging”; the other for fractional flow reserve using 
terms such as “FFR”, “fractional flow reserve”, “flow reserve”, 
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“coronary flow reserve”, and “coronary pressure reserve”. The 
terms from the two subsets were combined in 1:1 combination 
using Boolean operators; and finally, results from all the pos-
sible combinations were downloaded into an EndNote library. 
Based on our research question, articles from the reference 
lists relevant to the clinical question were screened by an in-
dependent author.
Selection criteria and study collection
All observational (retrospective/prospective) studies and rand-
omized control trials (RCT) on SCMR and FFR till September 
30, 2019, were evaluated. Articles comparing the diagnostic 
accuracy of SCMR perfusion scan with FFR were included in 
the study. Papers with insufficient data, review articles, case 
reports, editorials, and conference papers were excluded.
Data extractions
Three authors independently screened titles and abstracts of all 
articles for relevance. A fourth author selected articles that met 
inclusion criteria. The full texts of articles that were potential-
ly relevant to the study were screened by all the four authors 
to confirm eligibility. Baseline characteristics of the included 
population were reviewed, and data were collected for quality 
assessment to ensure study cohorts were statistically compa-
rable. Risk factors for CAD, such as hypertension (HTN), hy-
perlipidemia (HLD), smoking, diabetes mellitus (DM), prior 
myocardial infarction (MI) and prior CAD were compared in 
each group of the included study to ensure comparability of 
the included population. Data were extracted into a combined 
Excel sheet. Disagreements were resolved by mutual consen-
sus and after group discussion. The primary outcome was to 
determine the diagnostic accuracy of SCMR versus FFR for 
CAD severity.
Data and quality analysis
Raw data regarding the true and false positives and true and 
false negatives of each included study were obtained; and the 
combined measures of test accuracy (i.e., sensitivity, specifici-
ty, and diagnostic odds ratio (DOR)) for SCMR perfusion were 
calculated, keeping FFR as a standard. A bivariate model was 
obtained from data fitting. The parameters from the bivariate 
model were transformed into hierarchical summary receiver 
operating characteristic (HSROC) estimates. The area under 
the summary HSROC curve (AUC) was calculated to reveal 
the probability of accurately ranked diagnostic test values for 
a random pair of subjects (one with disease and one without 
disease). Chi-squared (χ2) tests were conducted to evaluate the 
heterogeneity of sensitivities and specificities among all stud-
ies. Subgroup analysis based on the resolution of SCMR and 
FFR cutoff points was performed to explore the potential het-
erogeneity factors using subgroup and meta-regression analy-
sis. The statistical analysis was performed using the diagnostic 
accuracy statistical model on Stata and R mad package.
Quality of included studies
Quality of the included studies was assessed for potential bias 
and applicability concerns using the Quality Assessment of 
Diagnostic Accuracy Studies (QUADAS-2) standard question-
naire. The overall risk of bias and applicability concerns based 
on patient selection, index and reference standard, and the time 
duration between these tests were of low concern. Approxi-
mately 40% of studies either did not mention the duration or 
had more than 4 weeks difference between the aforementioned 
diagnostic tests. Only one study (Schuchlenz et al) had insuf-
ficient bias assessment data posing a 3% unknown bias risk to 
the index and reference standard tests [3] (Fig. 1). Twenty-five 
percent of the studies did not specify the baseline characteris-
tics of its subjects and were stratified under the high-risk selec-
tion bias group (Fig. 2).
Results
Search results and study characteristics
The initial search revealed 3,921 articles. After the removal 
of irrelevant and duplicate items, 238 articles were deemed 
relevant for full-text review. We further excluded 210 articles 
based on our selection criteria; and 28 studies were included 
for final analysis [3-30]. The preferred reporting items for sys-
tematic review and meta-analysis (PRISMA) flow diagram are 
shown in Figure 3.
A total of 2,387 patients and 3,936 coronary vessels were 
included [3-30]. Mean age was 63 years. Seventeen studies 
used 0.8, and 11 articles used 0.75 as FFR cutoff. Studies using 
both 1.5T (18) and 3.0T (10) SCMR spatial resolution were 
included. Semi-quantitative data analysis was employed in 10 
studies, quantitative in nine studies, while the method of data 
analysis was not specified in the remainder. A time interval of 4 
weeks or less was present between SCMR and FFR in 16 of the 
included studies, more than 4 weeks in three studies, and not 
specified in eight studies. Subjects included in all the available 
studies had a variable prevalence of the baseline characteris-
tics and comorbidities, including prior MI, CAD, DM, HTN, 
multivessel disease, and smoking. The detailed characteristics 
of the included studies are summarized (Supplementary Mate-
rial 1, www.cardiologyres.org).
Figure 1. Overall risk of bias on the QUADAS-2 tool of the included 
studies in our study. QUADAS-2: the Quality Assessment of Diagnostic 
Accuracy Studies.
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Patient-level pooled diagnostic accuracy
At the patient level, pooled sensitivity and specificity for per-
fusion SCMR were 0.86 (95% confidence interval (CI), 0.79 
- 0.91) and 0.86 (95% CI, 0.82 - 0.90), respectively (Fig. 4a, 
b). The DOR on a per-patient basis was 48.5 (95% CI, 23.52 - 
100.41). The absolute AUC was 0.91, while partial AUC was 
0.78 (Fig. 5). The test for equality of sensitivities showed mod-
erate to severe heterogeneity I2 = 88% (χ2 = 137.17, df = 16, P 
value ≤ 2 × 10-16), while moderate heterogeneity was observed 
among the studies selected for equality of pooled specificities 
I2 = 66% (χ2 = 50.59, df = 16, P value = 1.85 × 10-5).
Coronary-territory pooled diagnostic accuracy
At vessel level, SCMR showed an overall sensitivity of 0.82 
(95% CI, 0.76 - 0.88), and specificity of 0.88 (95% CI, 0.84 - 
0.94) compared to FFR (Fig. 6a, b). The absolute AUC, partial 
AUC and DOR were 0.91, 0.85 and 37.95 (95% CI, 22.60 - 
63.73), respectively (Fig. 7). The test for equality of diagnostic 
accuracy showed moderate to severe heterogeneity among the 
studies selected for sensitivity (I2 = 89%, χ2 = 204.5, df = 21, P 
≤ 2 × 10-16), and specificity (I2 = 85%, χ2 = 142.9, df = 21, P ≤ 
2 × 10-16).
Subgroup analysis based on FFR threshold
Pooled diagnostic accuracy was stratified based on the two 
reported FFR thresholds. At the vessel level, sensitivity and 
Figure 2. Risk of bias on the QUADAS-2 tool of the individual studies 
included in our meta-analysis. QUADAS-2: the Quality Assessment of 
Diagnostic Accuracy Studies.
Figure 3. PRISMA flow diagram showing the selection of studies from 
all databases. PRISMA: preferred reporting items for systematic review 
and meta-analysis.
Articles © The authors   |   Journal compilation © Cardiol Res and Elmer Press Inc™   |   www.cardiologyres.org148
Diagnostic Accuracy of CMR Versus FFR Cardiol Res. 2020;11(3):145-154
specificity at the lower FFR threshold (0.8) were significantly 
higher at 0.88 (95% CI, 0.84 - 0.91) and 0.89 (95% CI, 0.82 
- 0.93), compared to 0.80 (0.68 - 0.88) and 0.87(0.82 - 0.91) 
for FFR at the higher threshold (0.75) (Supplementary Mate-
rial 2, www.cardiologyres.org). The DOR of FFR at the higher 
threshold was only 29.71, almost half of the DOR for the lower 
(0.80) cutoff (62.37 (95% CI, 32 - 118).
At the patient level, however, the higher cutoff exhibited 
a higher net sensitivity, 0.90 (95% CI, 0.84 - 0.94) but lower 
specificity 0.82 (95% CI, 0.73 - 0.88) compared to the lower 
cutoff, where the sensitivity was 0.85 (95% CI, 0.76 - 0.91) 
and specificity was 0.90 (95% CI, 0.84 - 0.93) (Supplementary 
Material 3, www.cardiologyres.org). The overall DOR favored 
the lower FFR threshold (52.3, 95% CI, 20.81 - 131.47) vs. 
(43.96, 95% CI, 18.98 - 101.84).
Subgroup analysis based on SCMR resolution
At vessel level, the specificity of SCMR at higher resolution 
(0.90, 95% CI 0.866 - 0.93) was significantly greater compared 
to lower resolution (0.85, 95% CI, 0.79 - 0.89) (Supplemen-
tary Material 4, www.cardiologyres.org), while the sensitivity 
was marginally higher for the lower resolution (0.85 vs. 0.81). 
The overall DOR was superior for higher resolution SCMR 
(44, 95% CI, 20 - 95) compared to (33, 95% CI, 16 - 66) for 
1.5T SCMR. At the patient level, the sensitivity and specificity 
were comparable at both resolutions (Supplementary Material 
5, www.cardiologyres.org).
Meta-regression analysis based on comorbidities
Meta-regression analysis based on covariates such as age 
(higher or lower than 65 years) and CAD prevalence were 
performed. SCMR had high sensitivity and specificity at 
0.92 and 0.94, respectively, for studies with CAD prevalence 
greater than 60%, compared with the sensitivity of 0.83, and 
specificity of 0.84 with prevalence of CAD less than 60% 
(Supplementary Material 6, www.cardiologyres.org). Corre-
Figure 4. (a) Forest plot depicting individual and pooled sensitivity at the patient level. (b) Forest plot depicting individual and 
pooled specificity at the patient level.
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sponding values at the vessel level were lower (Supplemen-
tary Material 6, www.cardiologyres.org). For both younger 
and older populations, the SCMR sensitivity was 0.86, but a 
higher specificity was noted for the younger population (0.89 
vs. 0.81) (Table 1). A comparison of patient and vessel level 
data has been shown in Supplementary Material 7 (www.car-
diologyres.org).
Discussion
If proven to have similar diagnostic efficacy, SCMR would 
be favorable to the current reference standard (FFR) due to 
its non-invasive nature, zero radiation exposure, and lower 
attenuation artifacts. Although myocardial perfusion SCMR 
has been possible for many years, the clinical sequence and 
data processing remain variable between centers. Our meta-
analysis estimated the diagnostic performance of perfusion 
SCMR in patients with known or suspected CAD and fo-
cused on comparing diagnostic accuracies at varying spatial 
resolution and FFR thresholds. Our results reconcile the var-
ying findings of previous studies and show high diagnostic 
accuracy of SCMR perfusion using FFR as a reference at pa-
tient level, with a sensitivity of 0.86 and specificity of 0.86. 
Subgroup analysis for the FFR threshold of lower (0.8) com-
pared to higher (0.75) showed better sensitivity and specific-
ity (about 90%) for the former. Further analysis showed that 
for higher spatial resolution of SCMR (3.0T), the sensitivity 
and specificity were also greater at 87% and 90%, respec-
tively.
FFR is calculated as the ratio of hyperemic pressure dif-
ference across coronary lesions compared to theoretical maxi-
mum flow in healthy coronary arteries [31]. FFR is considered 
the gold standard and has been proven to improve event-free 
survival in coronary revascularization [32]. However, for all 
its benefits, it has yet to gain widespread acceptance due to the 
invasive nature of the procedure [32]. As mentioned above, 
SCMR perfusion imaging, which is a non-invasive procedure, 
would seek to allay the concerns around the risks of FFR while 
offering a similar diagnostic profile. Interpretation is based on 
coronary flow reserve (CFR), which is driven by the pressure 
gradient between systemic diastolic and left ventricular end-
diastolic pressure at maximal vasodilation and under medica-
tion-induced stress. With vasodilator CMR (particularly using 
regadenoson, the most commonly used vasodilator currently), 
the perfusion defects are related to relative differences in blood 
flow between myocardium subtended by normal vs. stenotic 
coronary arteries [31]. The percentage of the ischemic territory 
serves as an indirect indicator of coronary artery stenosis, and 
is correlated against the findings of FFR [32].
On review of previously published meta-analyses, we 
noticed inconsistencies in the number of included studies. 
More contemporary studies did not always include all pre-
viously published data and had additional limitations due to 
outcome biases [2, 33-37]. Studies more stringent in their in-
clusion criteria, perhaps overestimated the diagnostic accu-
racy of SCMR owing to a positive selection bias. Danad et al 
(2016, four studies) reported a patient-based SCMR accuracy 
of greater than 90%; however, this was found to be lower at 
87% in a 2019 study by Yang et al, which included a much 
higher number of studies (19) [2, 36]. Vessel-level sensitiv-
ity analysis showed a similar discordance across all included 
studies. A common limitation observed was a lack of stratifi-
cation based on the different diagnostic thresholds for SCMR 
perfusion scans and FFR [34-37]. The study of Desai et al was 
the only one that used an FFR diagnostic threshold of 0.75 
as opposed to the standard 0.80, hampering the sensitivity of 
the SCMR perfusion scan by classifying a significant popula-
tion of patients having FFR of 0.75 - 0.80 as falsely “normal” 
[33]. Similarly, many included studies used 40-80% stenosis 
as inclusion criteria for stable CAD, when compared to the 
standard criteria of 50-75% stenosis. This would falsely clas-
sify subjects as having CAD compromising the sensitivity of 
SCMR (Table 2, [2, 33-37]). Moreover, differences in the con-
trast used across the studies also undermined the results; a few 
authors used exogenous contrast for stress images, while oth-
ers advocated the utilization of the paramagnetic properties 
of deoxyhemoglobin as an endogenous contrast to identify 
loss of T2 flair in the blood oxygen level-dependent (BOLD) 
SCMR [36].
We aimed to close the gap in clinical practice and obtain 
consensus on the preferred approach towards the diagnosis of 
CAD severity, by performing a comprehensive analysis of all 
available data to address the aforementioned limitations.
The objective was to compare the efficacy of two investi-
gative strategies for the management of patients with suspected 
Figure 5. Patient-level pooled diagnostic accuracy of CMR associated 
HROC vessel. CMR: cardiac magnetic resonance; HROC: hierarchical 
summary receiver operating characteristic.
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CAD at the level of both higher and lower FFR thresholds and 
SCMR spatial resolution. Our overall results indicate that at a 
lower FFR threshold and higher spatial resolution, SCMR per-
fusion is comparable to invasive angiography supplemented 
by FFR measurements in guiding the management of patients 
with stable CAD. Our subgroup analyses showed a 4% rise in 
the vessel-level specificity of SCMR with an increase in its 
resolution from 1.5T to 3.0T and an 8% increase in specific-
ity with the decreasing FFR threshold from 0.75 to 0.80. This 
improves the detection ability of SCMR perfusion to iden-
tify subendocardial ischemia. It also enables the detection of 
stress-mediated regional wall motion abnormalities at an ear-
lier stage [36]. Given the comparable accuracy of SCMR per-
fusion scan to the current invasive reference standard (FFR), 
SCMR should be seen as an attractive non-invasive alternative 
to current diagnostic approaches.
This meta-regression analysis showed that sensitivity and 
specificity of SCMR differed among populations with differing 
pre-test probability of CAD, indicating patient selection based 
on presentation and risk stratification is essential. In the high 
prevalence group, SCMR findings were equivalent to FFR, 
and overall specificity was high at 94%. In these selected pa-
tients, SCMR can serve as a non-invasive substitute for FFR 
without significant loss in diagnostic accuracy. Interestingly, 
meta-regression based on age cutoff of 65 years showed simi-
lar sensitivity but an 8% lower specificity in the older popula-
tion. One can argue that microvascular disease as a result of 
advancing age, smoking, and atherosclerosis can potentially 
affect SCMR perfusion imaging more than the FFR, and can 
have a detrimental effect on diagnostic accuracy. Stress CMR 
perfusion defects can be due to epicardial CAD and/or micro-
vascular CAD. FFR on the other hand can be falsely in the 
“normal” range because of severe microvascular CAD, even 
in the presence of epicardial CAD. Thus, stress CMR is argu-
ably more sensitive because unlike FFR, it “accounts for” the 
possibility of microvascular CAD, and the diagnostic accuracy 
comparisons may actually be affected because of a flawed ref-
erence standard (FFR).
Figure 6. (a) Forest plot depicting individual and pooled sensitivity at the vessel level. (b) Forest plot depicting individual and 
pooled specificity at the vessel level.
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Limitations
A few of the included studies performed a direct comparison 
of SCMR perfusion scan with FFR, an observation that may 
underscore the restricted availability of SCMR to advanced 
centers. Paradoxically, a lower rate of diagnostic accuracy is 
expected when SCMR becomes more widely available, lead-
ing to possible imprudent use.
We believe that the conceptual differences between these 
tests are irrefutable. FFR assumes static endothelial function 
on either side of the coronary lesion and an intact microcircula-
tion. Thus, findings are reliable in large coronary arteries but are 
often underappreciated in microcirculation. In contrast, SCMR 
assesses the coronary vasculature in its entirety. FFR identifies 
the hemodynamic significance and functional relevance of coro-
nary lesions, but gives no direct indication of the size of territory 
at risk of ischemia or its viability. SCMR, on the other hand, 
is a surrogate marker of coronary stenosis, an indirect measure 
of the degree of functional and anatomic coronary compromise 
based on the identification of myocardial ischemia. This techni-
cal discrepancy poses some theoretical risk of inconsistency and 
unreliability between the two diagnostic modalities.
Conclusions
SCMR can be used as a confirmation test for patients with a 
high pretest probability of CAD and as an exclusionary test 
for low-risk patients due to its high specificity and sensitiv-
ity compared to FFR, respectively. A lower FFR threshold of 
Figure 7. Vessel-level pooled diagnostic accuracy of CMR associated 
HROC. CMR: cardiac magnetic resonance; HROC: hierarchical sum-
mary receiver operating characteristic.
Table 1.  Meta-Regression Analysis on the Basis of CAD Prevalence and Age of the Patients in Included Studies
Variable Sensitivity (95% CI) Specificity (95% CI) DOR
Vessel level, MI > 60% 0.84 (0.77 - 0.88) 0.86 (0.81 - 0.89) 32 (19 - 53)
Patient, MI > 60% 0.92 (0.88 - 0.94) 0.94 (0.92 - 0.96) 12 (10 - 33)
Vessel level, MI < 60% 0.81 (0.66 - 0.91) 0.88 (0.82 - 0.92) 34 (14 - 80)
Patient, MI < 60% 0.82 (0.74 - 0.89) 0.84 (0.81 - 0.87) 27 (15 - 50)
Vessel level, Age < 65 0.82 (0.74 - 0.88) 0.89 (0.85 - 0.92) 34 (14 - 80)
Patient, Age < 65 0.86 (0.79 - 0.91) 0.89 (0.85 - 0.93) 58 (26 - 126)
Vessel level, Age > 65 0.86 (0.71 - 0.94) 0.81 (0.72 - 0.88) 28 (12 - 67)
CAD: coronary artery disease; MI: myocardial infarction; 95% CI: 95% confidence interval; DOR: diagnostic odds ratio.




Patient level Vessel level
Desai et al, 2013 [33] 12 89.1%, 84.9% 87.7%, 88.6% Used 0.75 only
Li et al, 2014 [34] 14 90%, 87% 89%, 86% No stratification based on thresholds
Jiang et al, 2016 [35] 20 88%, 88% 86%, 88% No stratification based on thresholds
Danad et al, 2017 [36] 4 90%, 94% 91%, 85% No stratification based on thresholds
Dai et al, 2016 [37] 21 88%, 84% 87%, 89% No stratification based on MRI thresholds
Yang et al, 2019 [2] 19 87%, 87% 85%, 89% CAD 50-75%
CAD: coronary artery disease.
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0.8 and a higher SCMR resolution of 3.0T, in particular, were 
associated with the highest diagnostic accuracy. SCMR repre-
sents advances over FFR in the detection of CAD severity, due 
to its non-invasive nature, being readily available and offering 
a comparable sensitivity and specificity.
Supplementary Material
Suppl 1. Characteristics of Included Studies.
Suppl 2. HROC for FFR of 0.75 and 0.8 at the vessel level.
Suppl 3. HROC for FFR of 0.75 and 0.8 at the patient level.
Suppl 4. HROC for CMR at vessel level at spatial resolution 
of 1.5T and 3T.
Suppl 5. HROC for CMR at patient level at spatial resolution 
of 1.5T.
Suppl 6. Meta-regression based on the prevalence of MI < 
60% at the patient level, MI > 60% at the vessel level, and MI 
< 60% at the vessel level.
Suppl 7. Meta-regression based on the age < 65 at the patient 
level, < 65 at the patient level, and > 65 at the vessel level.
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